Djokovic Owns 80% Of COVID Cure Search Pharma

Reuters reports:

The pandemic has blocked Novak Djokovic’s march to tennis history, so the 34-year-old may be pinning his hopes on a cure for COVID to get his hands on another glorious grand slam before time runs out.

The Serbian superstar, who became a focus of the global vaccine debate over his failed attempt to enter Australia without being inoculated, holds a majority stake in a Danish biotech firm aiming to develop a treatment to counter COVID-19, the company’s CEO told Reuters.

QuantBioRes boss Ivan Loncarevic, who described himself as an entrepreneur, said the tennis player’s acquisition of the 80% stake was made in June 2020 but declined to say how much it was.

Read the full article.

Unvaccinated tennis superstar Novak Djokovic purchases 80% of Danish biotech firm QuantBioRes, aiming to develop a medical treatment against COVID-19. https://t.co/IaMYpM51gH

— Rappler Sports (@RapplerSports) January 20, 2022

The pandemic has blocked Novak Djokovic’s march to tennis history, so the 34-year-old may be pinning his hopes on a cure for COVID to get his hands on another glorious grand slam before time runs out https://t.co/rDJ7TZ6mgh

— Economic Times (@EconomicTimes) January 20, 2022